Lanzkowsky Manual of Pediatric Hematology and Oncology

4. Auflage 2005
ISBN: 978-0-08-049731-0
Verlag: Elsevier Science & Techn.
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 856 Seiten, Web PDF

Entirely updated to reflect modern thinking and protocols, the Manual of Pediatric Hematology and Oncology provides concise information needed for the day-to-day management of children with pediatric hematologic and oncologic diseases. The clear style allows readers to make an accurate diagnosis and permits him/her to treat patients even if they have not had extensive previous hematologic or oncologic experience. Pertinent advances in molecular genetics, cytogenetics, immunology, transplantation and biochemistry are the result of 40 years of practical experience by the author in the management of patients and incorporates various contributors who have had extensive clinical experience. - Features numerous tables, flow diagrams, protocols, and algorithms for quick access of essential clinical information necessary for the diagnosis and management of these diseases in children - Designed as a concise, easy to use guide for medical students, residents, fellows, pediatric hematologists/oncologists, pediatric nurses and nurse practitioners - Much of the practical information contained in this manual is not found in standard textbooks - Straightforward style without any redundant words or references

Autoren/Hrsg.

Lanzkowsky, Philip

Inhaltsverzeichnis

1;Front Cover;1
2;Manual of Pediatric Hematology and Oncology;4
3;Copyright Page;5
4;CONTENTS;8
5;Contributors;10
6;Preface to Fourth Edition;12
7;Preface to Third Edition;14
8;Preface to Second Edition;16
9;Preface to First Edition;18
10;Chapter 1. Classification and Diagnosis of Anemia During Childhood;20
11;Chapter 2. Anemia During the Neonatal Period;31
12;Chapter 3. Iron-Deficiency Anemia;50
13;Chapter 4. Megaloblastic Anemia;66
14;Chapter 5 . Hematologic Manifestations of Systemic Illness;90
15;Chapter 6. Bone Marrow Failure;113
16;Chapter 7. Hemolytic Anemia;155
17;Chapter 8. Polycythemia;218
18;Chapter 9. Disorders of White Blood Cells;228
19;Chapter 10. Disorders of Platelets;269
20;Chapter 11. Disorders of Coagulation;314
20.1;Hemostatic Disorders;314
20.2;Thrombotic Disorders;347
21;Chapter 12. Lymphadenopathy and Splenomegaly;382
22;Chapter 13. Lymphoproliferative Disorders, Myelodysplastic Syndromes, and Myeloproliferative Disorders;390
23;Chapter 14. Leukemias;434
24;Chapter 15. Hodgkin Disease;472
25;Chapter 16. Non-Hodgkin Lymphoma;510
26;Chapter 17. Central Nervous System Malignancies;531
27;Chapter 18. Neuroblastoma;549
28;Chapter 19. Wilms' Tumor;567
29;Chapter 20. Rhabdomyosarcoma and Other Soft-Tissue Sarcomas;580
30;Chapter 21. Malignant Bone Tumors;604
31;Chapter 22. Histiocytosis Syndromes;623
32;Chapter 23. Retinoblastoma;649
33;Chapter 24. Miscellaneous Tumors;664
34;Chapter 25. Hematopoietic Stem Cell Transplantation;688
35;Chapter 26. Supportive Care and Management of Oncologic Emergencies;714
36;Chapter 27. Evaluation, Investigations and Management of Late Effects of Childhood Cancer;768
37;Appendix 1. Hematologic Reference Values;794
38;Appendix 2. CD Antigen Designations;819
39;Appendix 3. Biological Tumor Markers;822
40;Appendix 4. Pharmacologic Properties of Commonly Used Chemotherapy Agents;824
41;Index;827